PubMed Health⌕ Search

Biomedical subjects

C D Hill

Publications and source records attributed to C D Hill.

At least 19 recordsLinked to original sources

Descriptive epidemiology of injury and illness among cruise ship passengers.

STUDY OBJECTIVE: To provide information, which can be used in the formation of guidelines concerning medical facilities and staff on cruise ships, on the descriptive epidemiology of the medical conditions encountered by cruise ship physicians. METHODS: A retrospective descriptive epidemiologic study design was used to evaluate patient physician encounters on cruises originating in a calendar-year period for the 4 ships of a major cruise ship line with cruises originating in the United States. Demographic data regarding sex and age of the passengers on these ships were available for each cruise. We collected information on patient age, sex, chief complaint, diagnoses, treatment, and patient disposition recorded in the patients' medical records in the ships' medical logs. RESULTS: Seven thousand one hundred forty-seven new patient visits occurred in a population of 196,171 passengers and 1,537,298 passenger days; 56.7% of passengers were female, and 60.7% of patients were female; 43.3% of passengers and 39.6% of patients were male. Visits to the ship infirmaries were made for the following reasons: 18.2% of visits were related to injuries, 69.3% were related to medical conditions, and 12.5% were unspecified or other conditions. The most common diagnosis was respiratory tract infection (29.1%); 11% of patients had a serious or potentially life-threatening diagnosis. The most common group of prescription medications prescribed was antibiotics. CONCLUSION: Many different injuries and illnesses occur on board cruise ships. The spectrum is similar in many respects to the patients presenting to emergency departments. Cruise lines must prepare for the initial treatment and stabilization of patients with serious illnesses or injuries with appropriately qualified and equipped medical personnel and establish procedures for disembarkation of patients to facilities capable of handling such conditions.

Adolescent↗

Lithium intolerance in a medical-psychiatric population.

This pilot study was designed to explore the tolerance and efficacy of lithium as an adjunctive prophylactic agent when added to maintenance antidepressant regimens following an episode of depression in an older medical-psychiatric population. In a randomized controlled trial, 27 depressed patients had either lithium carbonate or placebo added to their maintenance antidepressant (AD) regimen following an index episode of depression. Of 17 patients who received lithium carbonate, 76% (13/17) were unable to tolerate this agent for the duration of the study because of side effects (e.g., gastrointestinal disturbances or tremor). The four patients who tolerated lithium were monitored for relapse of depression over a 15-month follow-up period, and one relapsed (after a 49-week remission) whereas 60% (6/10) of the placebo patients relapsed. Cognitive functioning was stable in the lithium-treated patients who remained on therapy. The high rate of lithium intolerance in this study indicates that lithium dosing and serum levels must be conservatively managed in this clinical population.

Adjuvants, Pharmaceutic↗

Recovery and relapse in geriatric depression after treatment with antidepressants and ECT in a medical-psychiatric population.

The objective of this naturalistic, longitudinal treatment outcome study was to determine relapse rates in geriatric depression following treatment with antidepressants and electroconvulsive therapy in a medical-psychiatric population. Thirty-nine elderly patients (average age 71 years) with unipolar major depression were treated with either antidepressants (AD) or, if resistant to AD treatment, ECT followed by maintenance antidepressants. Patients were monitored over 18 months, and relapse rates were closely determined using the Longitudinal Interval Follow-up Evaluation (LIFE) and the 21-item Hamilton Depression Rating Scale. Although 90% of patients recovered from their index episode of depression, relapse rates were approximately 29%. These results indicate that in spite of high chances of recovery from geriatric depression, intensive psychopharmacologic and psychotherapeutic strategies are needed to decrease relapse rates in geriatric depression.

Aged↗

Predicting aggressive and socially disruptive behavior in a maximum security forensic psychiatric hospital.

The predictive utility of Hare, Hart, and Cox's Psychopathy Checklist Screening Version (PCL:SV) was assessed utilizing a sample of forensic psychiatric patients from Vernon State Hospital in Vernon, Texas. A sample of 55 patients were interviewed and rated on the PCL:SV. During a six month follow up, occurrences of self-harm (suicide attempts and self mutilation), aggression (verbal abuse and threats, irritability, belligerence, and fighting) escape potential (threats and attempts), and treatment refusal (medication, tests, and physician's appointments) were rated. Separate stepwise multiple regression analyses were performed utilizing patient's age, type of charges, documented history of alcohol/drug abuse and the PCL:SV as predictor variables. Results indicate that the PCL:SV is predictive of aggression and treatment noncompliance.

Adult↗

Improvement in depression-related cognitive dysfunction following ECT.

Long-term cognitive changes were observed in 8 depressed patients whose pretreatment cognitive impairment (depressive dementia or pseudodementia) resolved after treatment with ECT. Improved performance on the Mattis Dementia Rating Scale was maintained throughout a 4-year follow-up period. Improvements on Memory and Initiation and Perseveration subscales were most consistent over time. These aspects of cognitive functioning may be the most susceptible to the effects of depression, and this may be a factor to consider in clinically evaluating older patients with both depression and cognitive impairment. The findings indicate that elderly patients with cognitive dysfunction secondary to depression may experience improvement in cognitive functioning that is stable over time with remission of the affective disorder.

Aged↗

Rehospitalization rates in older depressed adults after antidepressant and electroconvulsive therapy treatment.

OBJECTIVE: To determine (1) if a "high risk" period for rehospitalization can be identified in a population of depressed older adults and (2) if age of onset and previous history of depression is associated with an increased risk of rehospitalization. DESIGN: Naturalistic, longitudinal treatment outcome study. SETTING: Medical-psychiatry unit and outpatient clinic at a university hospital. PATIENTS: Ninety-four older adults diagnosed with major depression based on SCID and DSM-III-R criteria who were hospitalized for treatment. INTERVENTIONS: All patients were initially hospitalized on a medical-psychiatry unit and treated with either antidepressants or electroconvulsive therapy. MEASUREMENTS: Patients were initially evaluated with the Structured Clinical Interview for DSM-III-R (SCID), the Hamilton Depression Rating Scale, and a battery of neuro-psychological and behavioral tests. Patients were followed over time with an average follow-up interval of 3.09 + 1.45 years, and the date of the first psychiatric rehospitalization (if any) was recorded. RESULTS: Approximately 43.6 percent of the total sample required at least one psychiatric rehospitalization. The greatest risk of rehospitalization occurred in the first 18 months. No significant differences were noted between patient groups treated with ECT and those treated with antidepressants or between patients with a younger and those with an older age of onset of depressive disorder. A statistical trend was observed in which patients without previous episodes of depression had a lower overall rate of rehospitalization compared with patients with one or more previous episodes of depression. CONCLUSIONS: There appears to be a relatively high risk of psychiatric rehospitalization in depressed older adults, particularly in the first 18 months. This rate of rehospitalization underscores the importance of providing maintenance therapy and intensive psychiatric supervision for a minimum of 18 months to 2 years during the course of a depressive episode requiring inpatient hospitalization.

Age Factors↗

Long-term outcome of treatment-resistant depression in older adults.

Seventeen elderly patients with treatment-resistant depression were reassessed 15 months and 4 years after treatment with an antidepressant agent or ECT. At 15 months 47% (seven of 15) were clinically improved, and at the 4-year follow-up 71% (10 of 14) were improved. These results indicate that treatment-resistant depression may improve over time because of either the natural course of the illness or persistent treatment efforts.

Age Factors↗

Long-term affective and cognitive outcome in depressed older adults.

OBJECTIVE: The purpose of this naturalistic study was to examine the long-term (15 months and 4 years) cognitive and affective outcome following treatment with either cyclic antidepressants or ECT in depressed older adults. METHOD: Fifty-five patients meeting criteria for major depression were rated as to cognitive impairment and were treated as clinically indicated with either a cyclic antidepressant or ECT. Long-term outcome was determined through psychometric retesting 15 months (N = 47) and approximately 4 years (N = 44) after treatment. RESULTS: Analysis of 15-month and 4-year outcome evaluations revealed that the majority of patients improved over time with respect to their depression, regardless of whether they exhibited pretreatment cognitive impairment or were treated with cyclic antidepressants or ECT. Fifteen months and 4 years after treatment, 72.3% and 83.7% of patients, respectively, exhibited clinically meaningful improvement. However, patients given both cyclic antidepressants and ECT demonstrated a relatively high rate of rehospitalization (50%) over the course of the 4 years. Except for patients who developed dementia, cognitive functioning remained stable or improved for the majority of patients. In patients who received ECT, those with normal pretreatment cognition had stable cognitive functioning over time and those who had pretreatment cognitive dysfunction showed improvement over the 4-year follow-up period. CONCLUSIONS: Results of this study indicate that the long-term prognosis of depression in older adults is generally favorable, although they may be prone to relapse and recurrence, which points to the need for rigorous monitoring and follow-up care.

Age Factors↗

Similarities and differences in memory deficits in patients with primary dementia and depression-related cognitive dysfunction.

The authors examined differences between the verbal memory performance of older patients with major depression (MD) alone; major depression with reversible depression-related cognitive dysfunction (MD/DRCD); and primary dementia and major depression (DEM/MD). Patients were evaluated before antidepressant treatment and 6 and 15 months after treatment. Of the three groups, patients with MD alone acquired significantly more information on the California Verbal Learning Test and showed a more pronounced primacy effect. Patients with DEM/MD were more likely to commit errors of intrusion. Although older depressed patients with MD/DRCD may resemble patients with DEM/MD on some aspects of verbal memory performance, differences may be observed in the types of learning errors they commit. Diagnostic implications are discussed.

Adult↗

Dysnomia in the differential diagnosis of major depression, depression-related cognitive dysfunction, and dementia.

This study examined naming abilities in three groups of older adults with: I) major depression alone, II) major depression with reversible cognitive dysfunction, and III) dementia with depression. Groups I and II differed significantly from dementia patients in total correct responses to a visual-confrontation naming task (Boston Naming Test). Qualitative aspects of naming, specifically types of errors characterizing each patient group, were examined, but no statistically significant differences among groups were observed. The results support the contention that the presence of dysnomia may be useful in discriminating cognitive abnormalities secondary to dementia from cognitive dysfunction associated with depression.

Aged↗

Cognitive deficits in delirium: assessment over time.

Delirium is commonly defined as a transient organic brain syndrome characterized by concurrent disorders of attention, perception, thinking, memory, psychomotor behavior, and the sleep-wake cycle. One of the difficulties in studying delirium is that symptoms tend to fluctuate over the course of the day. Pre-existing organic brain disease appears to be a significant risk factor for the development of delirium, and numerous studies have shown a high rate of delirium in patients with cerebrovascular disease, Parkinson's disease, and Alzheimer's disease. The cognitive deficits associated with delirium have not been widely studied in a systematic, quantitative fashion. Following resolution of the frank delirium, documented cognitive deficits can be observed, and may persist in a diluted form for a period of months. Residual cognitive deficits may be due to a minimal and persistent confusion or to an underlying brain disorder.

Cognition Disorders↗

Numerical tests of a method for simulating electrical potentials on the cortical surface.

A mathematical imaging method for simulating cortical surface potentials was introduced at recent neurosciences meetings [1a], [1b], [2] and was applied to elucidate the neural origins of evoked responses in normal volunteers and certain patient populations. This method consists of the solution of an inward harmonic continuation problem and its effect is to simulate data that has not been attenuated and smeared by the skull. This cortical imaging technique (CIT) is validated by applying it to artificially derived data. Pairs of dipolar sources with different depths and separations are introduced into a spherical conducting medium simulating the head. Scalp potential maps are constructed by interpolating the simulated data between 28 "scalp" electrode positions. Noise is added to the data to approximate the variability in measured potentials that would be observed in practice. CIT is used in each case to construct potential maps on layers concentric to and within the layer representing the scalp. In several instances when the dipole pair is deep and closely spaced, the sources cannot be separated by the scalp topographical maps but are easily separated by the "cortical" topographical maps. CIT is also applied to scalp-recorded potentials evoked by bilateral median nerve stimulation and pattern-reversal visual stimulation.

Brain Mapping↗

Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly.

OBJECTIVE: This study sought to ascertain the affective and cognitive outcome after tricyclic and electroconvulsive treatment of elderly medical-psychiatric patients meeting diagnostic criteria for major depression, some of whom had normal cognitive functioning and some of whom were cognitively impaired before treatment. METHOD: Patients who met criteria for major depression on the basis of a structured diagnostic interview and who scored 17 or more on the Hamilton Rating Scale for Depression were evaluated with the Mattis Dementia Rating Scale. The patients were then treated in a nonrandom manner with either tricyclic antidepressants or ECT (followed by tricyclic maintenance therapy). The majority of the patients treated with ECT had not responded previously to tricyclics. Follow-up psychometric testing was repeated in 6 months. RESULTS: Among the patients with normal pretreatment cognitive functioning, cognition was generally stable. Among the patients with pretreatment cognitive impairment, a substantial number--including those receiving ECT--demonstrated improvement in cognition. While the majority of patients improved with respect to both their affective and cognitive states, certain treatment-refractory subgroups were nevertheless identified. CONCLUSIONS: The data suggest that cognitive dysfunction associated with depression may improve after treatment in a substantial number of elderly patients, including those receiving ECT. Relapse rates, however, may be relatively high, and residual symptoms may persist, which emphasizes the need for optimal initial and long-term antidepressant strategies for this population.

Aged↗

The medical-psychiatric unit as a site for outcome research in dementia/depression syndromes.

The era of cross-sectional "snapshot" clinical epidemiology studies in consultation-liaison psychiatry, while still important, do not in themselves yield the critical outcome information needed to document both the clinical efficacy and cost-efficacy of timely psychiatric treatment of patients with concurrent medical-psychiatric illness. As consultation-liaison psychiatry has been plagued by problems regarding reimbursement for clinical services rendered and has only a few systematic outcome studies as yet documenting the effectiveness of treatment interventions, more prospective studies are desperately needed to confirm the value of our efforts. The era of proselytizing the virtues of consultation-liaison psychiatry is over, and as with every other area of psychiatric therapy, governmental policy makers and third party payors are appropriately demanding to see "proof" that our treatments are both clinically- and cost-effective. As may be seen from this brief overview of our research demonstrating the potential reversibility of disabling cognitive dysfunction in depressed medical-psychiatric patients and the efficacy of labetalol in decreasing cardiovascular complications from ECT in high risk medical patients, positive reports from clinical investigations that are strategically planned and implemented on specific populations form strong arguments for the clinical and probable cost efficacy of both consultation-liaison psychiatry and medical-psychiatric units.

Comorbidity↗

African trypanosomiasis in an American hunter in East Africa.

An American citizen acquired African trypanosomiasis while on a hunting safari in Sudan, East Africa. His travel history and rapid onset of symptoms, including fever, chills, headache, lethargy, and weight loss, were suggestive of Trypanosoma brucei rhodesiense infection, and trypanosomes were demonstrated in routine blood smears and buffy-coat preparations. Despite the presence of headaches, nuchal rigidity, and CSF pleocytosis, he was treated for non-CNS African trypanosomiasis, based on a normal CSF IgM level. This case report, along with a review of previously reported cases of imported African trypanosomiasis, illustrates the importance of clinical consideration of this rare, but often misdiagnosed, tropical illness in febrile patients returning from Africa.

Adult↗